Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
About this item
Full title
Author / Creator
Publisher
England: Informa Healthcare
Journal title
Language
English
Formats
Publication information
Publisher
England: Informa Healthcare
Subjects
More information
Scope and Contents
Contents
The immunostimulants 3-O-desacyl-4 -monophosphoryl lipid A (MPL) and the saponin QS-21 are part of licensed or candidate vaccines. MPL and QS-21 directly affect the innate immune response to orchestrate the quality and intensity of the adaptive immune response to the vaccine antigens. The combination of immunostimulants in different adjuvant formul...
Alternative Titles
Full title
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1586_erv_11_29
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1586_erv_11_29
Other Identifiers
ISSN
1476-0584
E-ISSN
1744-8395
DOI
10.1586/erv.11.29
